| Range | Attendees (n = 74) | Non-attendees (n = 26) | Test Statistic | p-value |
---|---|---|---|---|---|
Perceived Susceptibility | 3 – 15 | M = 9.5, SD = 0.8 | M = 9.6, SD = 0.9 | 1019.5b | 0.626 |
Perceived Benefits | 6 - 30 | M = 24.0, SD = 1.7 | M = 23.6, SD = 1.6 | 864.0b | 0.384 |
Perceived Barriers | 13 – 65 | M = 27.0, SD = 4.5 | M = 29.2, SD = 6.1 | -2.0a | 0.049* |
Cues to action | 7 – 35 | M = 27.6, SD = 2.8 | M = 25.9, SD = 4.4 | 726.5b | 0.061 |
Self-Efficacy | 7 – 35 | M = 24.9, SD = 2.7 | M = 24.2, SD = 2.7 | 783.0b | 0.129 |
Breast Cancer Identity | 8 – 40 | M = 30.8, SD = 1.9 | M = 29.9, SD = 2.5 | 776.0b | 0.124 |
Causes of Breast Cancer | 18 – 90 | M = 55.8, SD = 7.2 | M = 53.9, SD = 5.9 | 1.2a | 0.238 |
Cancer Timeline: Acute/Chronic | 2 – 10 | M = 6.1, SD = 0.8 | M = 5.9, SD = 0.8 | 839.0b | 0.295 |
Cancer Timeline: Cyclical | 1 – 5 | M = 3.6, SD = 0.7 | M = 3.4, SD = 0.7 | 829.5b | 0.221 |
Consequences | 8 – 40 | M = 28.8, SD = 2.3 | M = 28.1, SD = 1.9 | 744.0b | 0.083 |
Personal Control | 3 – 15 | M = 11.9, SD = 0.7 | M = 12.0, SD = 0.0 | 1014.0b | 0.432 |
Treatment Control | 3 – 15 | M = 10.0, SD = 0.6 | M = 9.9, SD = 0.6 | 865.0b | 0.265 |
Illness Coherence | 2 – 10 | M = 6.8, SD = 1.2 | M = 6.9, SD = 1.1 | 991.5b | 0.802 |
Emotional Representations | 3 – 15 | M = 12.1, SD = 2.3 | M = 12.4, SD = 1.8 | 991.5b | 0.811 |